ANI Pharmaceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ANIP | ANUHPHR.BO | VAISHALI.NS | 3933.HK | THEMISMED.NS | 603439.SS | |
|---|---|---|---|---|---|---|
| Market cap | 1.65B | 8.33B | 888.45M | 15.37B | 9.44B | 4.57B |
| P/E (TTM) | 15.5 | 19.3 | — | 28.9 | 23.5 | 87.0 |
| Forward P/E | 7.1 | 6.8 | — | 11.3 | — | 10.6 |
| Price/book | 2.6 | 2.3 | 1.3 | 0.8 | 2.4 | 2.7 |
| Dividend yield | — | 1.81% | — | 6.47% | 0.50% | 0.55% |
| 1-year change | −21.96% | −6.29% | −31.00% | −41.08% | −15.87% | −9.97% |
| Today | −0.87% | +0.29% | +1.19% | +6.41% | +2.13% | +3.48% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All ANIP news ›What to expect from ANI Pharmaceuticals’s (ANIP) Q3 earnings
Specialty pharmaceutical company ANI Pharmaceuticals ANIPwill be reporting earnings this Thursday before market open. Here’s what investors should know. ANI Pharmaceuticals beat analysts’ revenue expectations last quarter, reporting…
Top-Rated Stocks: ANI Pharmaceuticals Sees Composite Rating Climb To 97
BREAKING: Futures Rise; Musk Warns On Neocloud Rivals Investors.com will undergo scheduled maintenance from 6:00 PM ET to 9:00 PM ET and some features may be unavailable. We apologize for any inconvenience. ANI Pharmaceuticals (ANIP) saw…
ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsules
PRINCETON, N.J., Oct. 19, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Duloxetine Delayed-Release Capsules 20, 30 and 60 mg. ANI’s Duloxetine Delayed-Release Capsules…
ANI Pharmaceuticals (NASDAQ:ANIP) CEO Sells $388,206.00 in Stock
Nikhil Lalwani also recently made the following trade(s): View Our Latest Analysis on ANIP ANI’s portfolio includes Cortrophin Gel (repository corticotropin injection), a specialty therapy used for certain inflammatory and autoimmune…
ANI Pharmaceuticals CEO sells 5,400 shares
Under a trading plan, ANI Pharmaceuticals (ANIP) CEO sells shares at $71.89 on average. Stock Titan - [Form 4] ANI PHARMACEUTICALS INC Insider Trading Activity ANI Pharmaceuticals CEO sells 5,400 shares The reported trades were made under…
ANI Pharmaceuticals: Lalwani proposes $379K sale
Nikhil Lalwani proposes selling 5,400 shares of ANI Pharmaceuticals (ANIP). Stock Titan ANI Pharmaceuticals: Lalwani proposes $379K sale The notice also lists two earlier sales under its “10b5-1 Sales” heading, each involving 5,400 shares.…
ANI Pharmaceuticals’ Meredith Cook sells 500 shares
ANI Pharmaceuticals (ANIP) is a diversified biopharmaceutical company focused on rare disease, generics, and branded therapeutics across multiple specialties. - [Form 4] ANI PHARMACEUTICALS INC Insider Trading Activity ANI Pharmaceuticals’…
Engitix appoints Ryan Richardson to Board of Directors as company advances towards clinical development
LONDON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Engitix Ltd., a biotechnology company pioneering extracellular matrix (ECM)-based drug discovery and development in oncology, fibrosis and fibro-inflammatory diseases, today announced the…
ANI Pharmaceuticals reports Phase 4 eye‑implant trial met both endpoints
The uncontrolled SYNCHRONICITY study reported a 3.6-letter vision gain at six months, with improvements maintained through two years. In the United States, the Phase 4 SYNCHRONICITY eye-implant trial met both six-month endpoints in results…
ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results
PRINCETON, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the second quarter ended June 30, 2026. Second Quarter and…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net4
- manilatimes.net2
- biospace.com1
- defenseworld.net1
- investors.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.